FLT3-ITD has also been associated with malignant transformation of MDS [45,47] and a poor prognostic outcome in AML [42,44,48,49,50], with the ratio of mutant to wild-type alleles having an impact [51]. This evidence concerns the gene FLT3 and acute myeloid leukemia.